Home › Astrocytoma › Massachusetts › Boston
Astrocytoma clinical trials in Boston, MA
13 studies for Astrocytoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- Tufts Medical Center, Boston
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Implantable Microdevice In Primary Brain Tumors
RecruitingEarly phase 1
- Brigham and Women's Hospital, Boston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RecruitingPhase 1/2
- Research Site, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
- Tufts Medical Center, Boston
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
Recruiting
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Susan Chi, Boston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Dana-Farber Cancer Institute, Boston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
RecruitingObservational study
- Massachusetts General Hospital, Boston
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
RecruitingObservational study
- Massachusetts General Hospital, Boston
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
RecruitingObservational study
- Massachusetts General Hospital, Boston
Astrocytoma trials in other cities
- Houston, TX15 studies
- New York City, NY10 studies
- Chicago, IL9 studies
- Seattle, WA7 studies
- Philadelphia, PA7 studies
- Miami, FL7 studies
- Durham, NC7 studies
- San Francisco, CA6 studies
- Columbus, OH6 studies
- Aurora, CO6 studies
- Washington, DC5 studies
- Cincinnati, OH5 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.